Skip to main content

Day: May 9, 2023

Novo Nordisk A/S purchases B shares worth DKK 3,889 million from Novo Holdings A/S under the 2023 share repurchase programme

Bagsværd, Denmark, 9 May 2023 – Today, Novo Nordisk A/S has entered into an agreement to purchase 3,506,250 B shares of DKK 0.20 at a value of DKK 3,889 million from Novo Holdings A/S. The transaction is part of Novo Nordisk A/S’ 2023 share repurchase programme of up to a total of DKK 30 billion to be executed during a 12-month period beginning 1 February 2023. The transaction price is DKK 1,109.23 per share and has been calculated as the three-day volume weighted average market price from 4 May 2023 to 9 May 2023 in the open window following the announcement of Novo Nordisk A/S’ quarterly financial results. Prior to the sale of B shares, Novo Holdings A/S’ ownership of Novo Nordisk A/S was 28.4% of the share capital and 77.2% of the votes. Following the transaction, Novo Holdings A/S owns 537,436,000 A shares of DKK 0.20 and 98,597,750...

Continue reading

Disclosure of trading in own shares under a share buyback programme (1 to 5 May 2023)

Disclosure of trading in own shares under a share buyback programme Period : From 1 to 5 May 2023 Issuer’s registered name: Ipsos Issuer’s Identification code: 9695002OY2X35E9X8W87 Financial instrument reference: Ordinary shares – ISIN code FR0000073298 Reporting of transactions in aggregated form (per day and per trading venue)Issuer name Issuer Code Transaction date ISIN Code Daily total volume (in number of shares) Daily weighted average price of shares acquired Platform      ISIN Code (ISO 6166)     MIC code (ISO 10383)IPSOS 9695002OY2X35E9X8W87 2-May-23 FR0000073298 21 305 49,4608 XPARIPSOS 9695002OY2X35E9X8W87 2-May-23 FR0000073298 10 935 49,4177 DXEIPSOS 9695002OY2X35E9X8W87 2-May-23 FR0000073298 1 200 49,5178 TQEIPSOS 9695002OY2X35E9X8W87 2-May-23 FR0000073298 3 185 49,4469 AQEIPSOS 9695002OY2X35E9X8W87 3-May-23 FR0000073298 20...

Continue reading

Teck to Present at the BofA Securities 2023 Global Metals, Mining and Steel Conference May 16, 2023

VANCOUVER, British Columbia, May 09, 2023 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) Chief Executive Officer Jonathan Price will be presenting at the BofA Securities 2023 Global Metals, Mining and Steel conference on Tuesday, May 16, 2023 at 5:40 a.m. Eastern/2:40 a.m. Pacific time. The investor presentation will focus on maximizing value for shareholders and include information on company strategy, financial performance, and outlook. The presentation will be webcast through the following link at: https://bofa.veracast.com/webcasts/bofa/metalsminingsteel2023/idf0a930.cfm. Alternatively, the webcast with supporting slides will be available on Teck’s website at: www.teck.com. About TeckAs one of Canada’s leading mining companies, Teck is committed to responsible mining and mineral development...

Continue reading

Interoil announces proposed acquisition of an additional participation in Santa Cruz concessions

Oslo, 9 May 2023 Interoil Exploration and Production ASA (the “Company” or “IOX”) is pleased to announce the execution of a binding term sheet (the “Term Sheet”) whereby Interoil and the Argentine company Selva María Oil S.A. (“SMO”, and with Interoil each a “Buyer” and together the “Buyers”) undertake to acquire from Echo Energy Plc (“Echo”) and its subsidiaries Eco Energy CDL OP Ltd. and Eco Energy TA OP Ltd. (both such subsidiaries together with Echo, the “Sellers”) (i) 65% of the aggregate interest and assets in and to five exploitation concessions located in the Province of Santa Cruz, Argentina, namely CA-1 “Campo Bremen”, CA-4 “Moy Aike”, CA-6 “Chorrillos”, CA-10 “Palermo Aike” and CA-9 “Océano” (the “Exploitation Concessions’), and the related joint venture, as well as (ii) a 95% interest in...

Continue reading

React Gaming Announces Appointment to the Board of Directors and Management Cease Trade Order

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES MONTREAL, May 09, 2023 (GLOBE NEWSWIRE) — React Gaming Group Inc. (“React Gaming” or the “Corporation”) (TSXV: RGG, OTCQB: ITMZF) announces the appointment of Normand Bellemare to the board of directors. Mr. Bellemare has extensive experience in the field of sales, after receiving a Bachelor’s degree in Social Communication. Over the years, he has won several awards of excellence from major international companies. In 1998, he created a company, Runes Technologiques, which specializes in technological recruitment. Mr. Bellemare has also been in charge of sales at Renaps Info, a company that offers technological services. Management Cease Trade Order The Corporation announces that it has not met its filing deadline for its audited annual...

Continue reading

Total number of shares and voting rights at April 30, 2023

9 May 2023 Orange: information on the total number of shares and voting rights referred to in Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. In application of Article L. 22-10-46 of the French Commercial Code (Code de commerce), as from 3 April 2016, a double voting right is automatically granted to fully paid-up shares that have been held in registered form and under a single shareholder name for at least two years.Date Number of shares Number of treasury shares without voting rights Theoretical number of voting rights [1] Number of voting rights exercisable01/31/2023 2, 660, 056,599 1, 655,051 3, 122, 030,612 3, 120, 375,56102/28/2023 2, 660, 056,599 1, 281,171 3, 121, 957,722 3, 120, 676,55103/31/2023 2, 660, 056,599 613,910 3, 122,...

Continue reading

Fluxys Belgium – 9 May 2023 18:30 CET – Regulated information – Payment of dividend

The Ordinary General Meeting of Shareholders of 9 May 2023 decided to distribute a dividend for the financial year 2022 and set the gross amount at EUR 1.40 per share. The net dividend, after deduction of the 30% withholding tax, amounts to EUR 0.98 per share and is payable as from 17 May 2023. Holders of dematerialised and registered shares on 16 May 2023 will receive the dividend as from 17 May 2023 as follows:The dividend of dematerialised shares will be paid automatically by the financial intermediary holding the shares on behalf of the shareholder. The dividend of registered shares will be paid directly to the shareholders entered in the register. According to Euronext procedure: Ex date: 15.05.2023 / Record date: 16.05.2023 / Payment date: 17.05.2023

Continue reading

Logiq Appoints Technology Visionary and Investor, Peter Bordes, to Board of Directors

NEW YORK, May 09, 2023 (GLOBE NEWSWIRE) — Logiq, Inc. (OTCQX:LGIQ), a leading provider of digital consumer acquisition solutions, has appointed tech industry visionary and venture investor, Peter Bordes, to its board of directors. Following his appointment, the board consists of four directors, with two serving independently. Bordes has been a lifelong entrepreneur with more than 30 years of executive and board experience, leading private and public companies across AdTech, media, AI, fintech and technology sectors. He also brings to Logiq years of accomplishment in venture investing focused on disruptive technology innovation driving digital transformation. “We anticipate Peter’s extensive experience as a venture investor, senior executive and board member contributing significantly to our growth strategy and M&A initiatives,”...

Continue reading

Knight to Present at the 2023 RBC Capital Markets Global Healthcare Conference in New York City

MONTREAL, May 09, 2023 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 2023 RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023 at 10:30 am ET at the InterContinental New York Barclay hotel in New York City. About Knight Therapeutics Inc. Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Knight’s Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM. Knight Therapeutics Inc.’s shares...

Continue reading

Bulletin from Annual General Meeting in Hexatronic Group AB (publ)

Press release May 9, 2023Gothenburg, Sweden Bulletin from Annual General Meeting in Hexatronic Group AB (publ) The following resolutions were passed at the Annual General Meeting (the “AGM”) of Hexatronic Group AB (publ) (“Hexatronic” or the “Company”) held today on 9 May 2023 in Gothenburg, Sweden. Adoption of Income Statement and Balance Sheet for the Financial Year 2022 and Discharge from Liability The AGM adopted the income statements and the balance sheets for the Company and the group for the financial year 2022. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2022. Allocation of Profits The AGM resolved that a dividend of SEK 0.10 per share shall be paid and that the record date for receipt of the dividend shall be Thursday 11 May 2023. Election of Board Members, Auditors,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.